Age-modified forms of Amyloid-β as initiator of Alzheimer Disease pathogenesis and mediator of Aβ-tau interaction: a study in a Drosophila model and Aβ immunized human Alzheimer patients

Publications

Publications via OpenAIRE (1)

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease

Author(s): Andrew Stephen Phillips; Katie Gaimster; Christian Paul; Delphine Boche; Amritpal Mudher; Maria Luisa Moro; James A. R. Nicoll
Published in: BioMed Central Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-10 (2018) 2018
Permanent ID: PubMed Central ID:PMC5753481; PubMed ID:29298722; Digital Object Identifier:10.1186/s40478-017-0505-x